1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Neuromyelitis Optica Drug Market Size 2016-2026 2.1.2 Neuromyelitis Optica Drug Market Size CAGR by Region 2020 VS 2021 VS 2026 2.2 Neuromyelitis Optica Drug Segment by Type 2.2.1 Glucocorticoids 2.2.2 Glucocorticoids 2.2.3 Others 2.3 Neuromyelitis Optica Drug Market Size by Type 2.3.1 Global Neuromyelitis Optica Drug Market Size CAGR by Type 2.3.2 Global Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021) 2.4 Neuromyelitis Optica Drug Segment by Application 2.4.1 Acute Attack 2.4.2 Remission Prophylactic Treatment 2.5 Neuromyelitis Optica Drug Market Size by Application 2.5.1 Global Neuromyelitis Optica Drug Market Size CAGR by Application 2.5.2 Global Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021) 3 Neuromyelitis Optica Drug Market Size by Players 3.1 Neuromyelitis Optica Drug Market Size Market Share by Players 3.1.1 Global Neuromyelitis Optica Drug Revenue by Players (2019-2021E) 3.1.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players (2019-2021E) 3.2 Global Neuromyelitis Optica Drug Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Neuromyelitis Optica Drug by Regions 4.1 Neuromyelitis Optica Drug Market Size by Regions (2016-2021) 4.2 Americas Neuromyelitis Optica Drug Market Size Growth (2016-2021) 4.3 APAC Neuromyelitis Optica Drug Market Size Growth (2016-2021) 4.4 Europe Neuromyelitis Optica Drug Market Size Growth (2016-2021) 4.5 Middle East & Africa Neuromyelitis Optica Drug Market Size Growth (2016-2021) 5 Americas 5.1 Americas Neuromyelitis Optica Drug Market Size by Country (2016-2021) 5.2 Americas Neuromyelitis Optica Drug Market Size by Type (2016-2021) 5.3 Americas Neuromyelitis Optica Drug Market Size by Application (2016-2021) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Neuromyelitis Optica Drug Market Size by Region (2016-2021) 6.2 APAC Neuromyelitis Optica Drug Market Size by Type (2016-2021) 6.3 APAC Neuromyelitis Optica Drug Market Size by Application (2016-2021) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Neuromyelitis Optica Drug by Country (2016-2021) 7.2 Europe Neuromyelitis Optica Drug Market Size by Type (2016-2021) 7.3 Europe Neuromyelitis Optica Drug Market Size by Application (2016-2021) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Neuromyelitis Optica Drug by Region (2016-2021) 8.2 Middle East & Africa Neuromyelitis Optica Drug Market Size by Type (2016-2021) 8.3 Middle East & Africa Neuromyelitis Optica Drug Market Size by Application (2016-2021) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Global Neuromyelitis Optica Drug Market Forecast 10.1 Global Neuromyelitis Optica Drug Forecast by Regions (2021-2026) 10.1.1 Global Neuromyelitis Optica Drug Forecast by Regions (2021-2026) 10.1.2 Americas Neuromyelitis Optica Drug Forecast 10.1.3 APAC Neuromyelitis Optica Drug Forecast 10.1.4 Europe Neuromyelitis Optica Drug Forecast 10.1.5 Middle East & Africa Neuromyelitis Optica Drug Forecast 10.2 Americas Neuromyelitis Optica Drug Forecast by Countries (2021-2026) 10.2.1 United States Neuromyelitis Optica Drug Market Forecast 10.2.2 Canada Neuromyelitis Optica Drug Market Forecast 10.2.3 Mexico Neuromyelitis Optica Drug Market Forecast 10.2.4 Brazil Neuromyelitis Optica Drug Market Forecast 10.3 APAC Neuromyelitis Optica Drug Forecast by Region (2021-2026) 10.3.1 China Neuromyelitis Optica Drug Market Forecast 10.3.2 Japan Neuromyelitis Optica Drug Market Forecast 10.3.3 Korea Neuromyelitis Optica Drug Market Forecast 10.3.4 Southeast Asia Neuromyelitis Optica Drug Market Forecast 10.3.5 India Neuromyelitis Optica Drug Market Forecast 10.3.6 Australia Neuromyelitis Optica Drug Market Forecast 10.4 Europe Neuromyelitis Optica Drug Forecast by Country (2021-2026) 10.4.1 Germany Neuromyelitis Optica Drug Market Forecast 10.4.2 France Neuromyelitis Optica Drug Market Forecast 10.4.3 UK Neuromyelitis Optica Drug Market Forecast 10.4.4 Italy Neuromyelitis Optica Drug Market Forecast 10.4.5 Russia Neuromyelitis Optica Drug Market Forecast 10.5 Middle East & Africa Neuromyelitis Optica Drug Forecast by Region (2021-2026) 10.5.1 Egypt Neuromyelitis Optica Drug Market Forecast 10.5.2 South Africa Neuromyelitis Optica Drug Market Forecast 10.5.3 Israel Neuromyelitis Optica Drug Market Forecast 10.5.4 Turkey Neuromyelitis Optica Drug Market Forecast 10.5.5 GCC Countries Neuromyelitis Optica Drug Market Forecast 10.6 Global Neuromyelitis Optica Drug Forecast by Type (2021-2026) 10.7 Global Neuromyelitis Optica Drug Forecast by Application (2021-2026) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Neuromyelitis Optica Drug Product Offered 11.1.3 Pfizer Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Fresenius 11.2.1 Fresenius Company Information 11.2.2 Fresenius Neuromyelitis Optica Drug Product Offered 11.2.3 Fresenius Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.2.4 Fresenius Main Business Overview 11.2.5 Fresenius Latest Developments 11.3 Teva 11.3.1 Teva Company Information 11.3.2 Teva Neuromyelitis Optica Drug Product Offered 11.3.3 Teva Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.3.4 Teva Main Business Overview 11.3.5 Teva Latest Developments 11.4 Sandoz 11.4.1 Sandoz Company Information 11.4.2 Sandoz Neuromyelitis Optica Drug Product Offered 11.4.3 Sandoz Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.4.4 Sandoz Main Business Overview 11.4.5 Sandoz Latest Developments 11.5 Intas 11.5.1 Intas Company Information 11.5.2 Intas Neuromyelitis Optica Drug Product Offered 11.5.3 Intas Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Intas Main Business Overview 11.5.5 Intas Latest Developments 11.6 Gyjtrs 11.6.1 Gyjtrs Company Information 11.6.2 Gyjtrs Neuromyelitis Optica Drug Product Offered 11.6.3 Gyjtrs Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Gyjtrs Main Business Overview 11.6.5 Gyjtrs Latest Developments 11.7 NANG KUANG 11.7.1 NANG KUANG Company Information 11.7.2 NANG KUANG Neuromyelitis Optica Drug Product Offered 11.7.3 NANG KUANG Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.7.4 NANG KUANG Main Business Overview 11.7.5 NANG KUANG Latest Developments 11.8 Tianjin Kingyork 11.8.1 Tianjin Kingyork Company Information 11.8.2 Tianjin Kingyork Neuromyelitis Optica Drug Product Offered 11.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.8.4 Tianjin Kingyork Main Business Overview 11.8.5 Tianjin Kingyork Latest Developments 11.9 Baxter 11.9.1 Baxter Company Information 11.9.2 Baxter Neuromyelitis Optica Drug Product Offered 11.9.3 Baxter Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.9.4 Baxter Main Business Overview 11.9.5 Baxter Latest Developments 11.10 CSL 11.10.1 CSL Company Information 11.10.2 CSL Neuromyelitis Optica Drug Product Offered 11.10.3 CSL Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 CSL Main Business Overview 11.10.5 CSL Latest Developments 11. Grifols 11.11.1 Grifols Company Information 11.11.2 Grifols Neuromyelitis Optica Drug Product Offered 11.11.3 Grifols Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.11.4 Grifols Main Business Overview 11.11.5 Grifols Latest Developments 11.12 Octapharma 11.12.1 Octapharma Company Information 11.12.2 Octapharma Neuromyelitis Optica Drug Product Offered 11.12.3 Octapharma Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.12.4 Octapharma Main Business Overview 11.12.5 Octapharma Latest Developments 11.13 CBOP 11.13.1 CBOP Company Information 11.13.2 CBOP Neuromyelitis Optica Drug Product Offered 11.13.3 CBOP Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021) 11.13.4 CBOP Main Business Overview 11.13.5 CBOP Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Neuromyelitis Optica Drug Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Glucocorticoids Table 3. Major Players of Immunotherapies Table 4. Major Players of Others Table 5. Neuromyelitis Optica Drug Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021) Table 8. Neuromyelitis Optica Drug Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021) Table 11. Global Neuromyelitis Optica Drug Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Neuromyelitis Optica Drug Revenue Market Share by Players (2019-2021E) Table 13. Neuromyelitis Optica Drug Key Players Head office and Products Offered Table 14. Neuromyelitis Optica Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Neuromyelitis Optica Drug Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Neuromyelitis Optica Drug Market Size Market Share by Regions 2016-2021 Table 19. Americas Neuromyelitis Optica Drug Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Neuromyelitis Optica Drug Market Size Market Share by Country (2016-2021) Table 21. Americas Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021) Table 23. Americas Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021) Table 25. APAC Neuromyelitis Optica Drug Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Neuromyelitis Optica Drug Market Size Market Share by Region (2016-2021) Table 27. APAC Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021) Table 29. APAC Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021) Table 31. Europe Neuromyelitis Optica Drug Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Neuromyelitis Optica Drug Market Size Market Share by Country (2016-2021) Table 33. Europe Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021) Table 35. Europe Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Neuromyelitis Optica Drug Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Neuromyelitis Optica Drug Table 44. Key Application and Potential Industries of Neuromyelitis Optica Drug Table 45. Key Challenges of Neuromyelitis Optica Drug Table 46. Key Trends of Neuromyelitis Optica Drug Table 47. Global Neuromyelitis Optica Drug Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Neuromyelitis Optica Drug Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Neuromyelitis Optica Drug Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Neuromyelitis Optica Drug Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Neuromyelitis Optica Drug Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Neuromyelitis Optica Drug Market Size Market Share Forecast by Application (2021-2026) Table 53. Pfizer Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 54. Pfizer Neuromyelitis Optica Drug Product Offered Table 55. Pfizer Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Pfizer Main Business Table 57. Pfizer Latest Developments Table 58. Fresenius Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 59. Fresenius Neuromyelitis Optica Drug Product Offered Table 60. Fresenius Main Business Table 61. Fresenius Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Fresenius Latest Developments Table 63. Teva Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 64. Teva Neuromyelitis Optica Drug Product Offered Table 65. Teva Main Business Table 66. Teva Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Teva Latest Developments Table 68. Sandoz Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 69. Sandoz Neuromyelitis Optica Drug Product Offered Table 70. Sandoz Main Business Table 71. Sandoz Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Sandoz Latest Developments Table 73. Intas Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 74. Intas Neuromyelitis Optica Drug Product Offered Table 75. Intas Main Business Table 76. Intas Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Intas Latest Developments Table 78. Gyjtrs Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 79. Gyjtrs Neuromyelitis Optica Drug Product Offered Table 80. Gyjtrs Main Business Table 81. Gyjtrs Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Gyjtrs Latest Developments Table 83. NANG KUANG Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 84. NANG KUANG Neuromyelitis Optica Drug Product Offered Table 85. NANG KUANG Main Business Table 86. NANG KUANG Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. NANG KUANG Latest Developments Table 88. Tianjin Kingyork Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 89. Tianjin Kingyork Neuromyelitis Optica Drug Product Offered Table 90. Tianjin Kingyork Main Business Table 91. Tianjin Kingyork Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Tianjin Kingyork Latest Developments Table 93. Baxter Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 94. Baxter Neuromyelitis Optica Drug Product Offered Table 95. Baxter Main Business Table 96. Baxter Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Baxter Latest Developments Table 98. CSL Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 99. CSL Neuromyelitis Optica Drug Product Offered Table 100. CSL Main Business Table 101. CSL Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. CSL Latest Developments Table 103. Grifols Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 104. Grifols Neuromyelitis Optica Drug Product Offered Table 105. Grifols Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 106. Grifols Main Business Table 107. Grifols Latest Developments Table 108. Octapharma Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 109. Octapharma Neuromyelitis Optica Drug Product Offered Table 110. Octapharma Main Business Table 111. Octapharma Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 112. Octapharma Latest Developments Table 113. CBOP Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors Table 114. CBOP Neuromyelitis Optica Drug Product Offered Table 115. CBOP Main Business Table 116. CBOP Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 117. CBOP Latest Developments List of Figures Figure 1. Neuromyelitis Optica Drug Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Neuromyelitis Optica Drug Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Neuromyelitis Optica Drug Market Size Market Share by Type in 2020 Figure 7. Neuromyelitis Optica Drug in Acute Attack Figure 8. Global Neuromyelitis Optica Drug Market: Acute Attack (2016-2021) & ($ Millions) Figure 9. Neuromyelitis Optica Drug in Remission Prophylactic Treatment Figure 10. Global Neuromyelitis Optica Drug Market: Remission Prophylactic Treatment (2016-2021) & ($ Millions) Figure 11. Global Neuromyelitis Optica Drug Market Size Market Share by Application in 2020 Figure 12. Global Neuromyelitis Optica Drug Revenue Market Share by Player in 2020 Figure 13. Global Neuromyelitis Optica Drug Market Size Market Share by Regions (2016-2021) Figure 14. Americas Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions) Figure 15. APAC Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions) Figure 16. Europe Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions) Figure 17. Middle East & Africa Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions) Figure 18. Americas Neuromyelitis Optica Drug Market Size Market Share by Country in 2020 Figure 19. Americas Neuromyelitis Optica Drug Market Size Market Share by Type in 2020 Figure 20. Americas Neuromyelitis Optica Drug Market Size Market Share by Application in 2020 Figure 21. United States Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 22. Canada Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 23. Mexico Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 24. APAC Neuromyelitis Optica Drug Market Size Market Share by Regions in 2020 Figure 25. APAC Neuromyelitis Optica Drug Market Size Market Share by Type in 2020 Figure 26. APAC Neuromyelitis Optica Drug Market Size Market Share by Application in 2020 Figure 27. China Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 28. Japan Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 29. Korea Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 30. Southeast Asia Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 31. India Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 32. Australia Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 33. Europe Neuromyelitis Optica Drug Market Size Market Share by Country in 2020 Figure 34. Europe Neuromyelitis Optica Drug Market Size Market Share by Type in 2020 Figure 35. Europe Neuromyelitis Optica Drug Market Size Market Share by Application in 2020 Figure 36. Germany Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 37. France Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 38. UK Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 39. Italy Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 40. Russia Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 41. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Region in 2020 Figure 42. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Type in 2020 Figure 43. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Application in 2020 Figure 44. Egypt Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 45. South Africa Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 46. Israel Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 47. Turkey Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 48. GCC Country Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions) Figure 49. Americas Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 50. APAC Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 51. Europe Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 52. Middle East & Africa Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 53. United States Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 54. Canada Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 55. Mexico Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 56. Brazil Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 57. China Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 58. Japan Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 59. Korea Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 60. Southeast Asia Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 61. India Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 62. Australia Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 63. Germany Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 64. France Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 65. UK Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 66. Italy Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 67. Russia Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 68. Spain Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 69. Egypt Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 70. South Africa Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 71. Israel Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 72. Turkey Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions) Figure 73. GCC Country Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)